Brad Fowler
22Patents
15h-index
14Co-inventors
74Inventor score
Filing activity: Feb 19, 2004 → Jun 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7483747B2 | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy | Emerging Cross-Sectional Technologies | 277 | Expired |
| US7684866B2 | Apparatus and methods for applying neural stimulation to a patient | Human Necessities | 163 | Expired |
| US7353064B2 | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction | Human Necessities | 121 | Expired |
| US7983762B2 | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy | Emerging Cross-Sectional Technologies | 57 | Active |
| US7437196B2 | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects | Human Necessities | 55 | Active |
| US7565200B2 | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects | Human Necessities | 46 | Expired |
| US7742820B2 | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects | Human Necessities | 40 | Active |
| US8126562B2 | Apparatus and methods for applying neural stimulation to a patient | Human Necessities | 30 | Active |
| US8090446B2 | Methods and systems for establishing neural stimulation parameters and providing neural stimulation | Human Necessities | 30 | Active |
| US8135472B2 | Systems and methods for treating autism spectrum disorders (ASD) and related dysfunctions | Human Necessities | 29 | Active |
| US9186510B2 | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy | Emerging Cross-Sectional Technologies | 29 | Active |
| US8718777B2 | Methods and systems for intracranial neurostimulation and/or sensing | Human Necessities | 27 | Active |
| US7917225B2 | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects | Human Necessities | 19 | Active |
| US7908009B2 | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects | Human Necessities | 18 | Active |
| US8538537B2 | Systems and methods for providing targeted neural stimulation therapy to address neurological disorders, including neuropyschiatric and neuropyschological disorders | Human Necessities | 15 | Active |
| US8606361B2 | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy | Emerging Cross-Sectional Technologies | 15 | Active |
| US8929991B2 | Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits | Human Necessities | 14 | Active |
| US9808627B2 | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy | Emerging Cross-Sectional Technologies | 12 | Active |
| US7949401B2 | Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods | Human Necessities | 9 | Active |
| US11786729B2 | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy | Emerging Cross-Sectional Technologies | 0 | Active |
| US8504159B2 | Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods | Human Necessities | 0 | Active |
| US11065449B2 | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.